The outlook has brightened for federal science budgets, but political appointees are likely to have a big say in how that ...

We can no longer lend our credibility to an organization that has lost its integrity,” write four scientists and ...

The US president vowed to ‘end childhood cancer’. But his administration is dismantling the search for a cure and sending families scrambling for treatment ...

Unfortunately, many rural communities like mine are facing a growing health care crisis, with hospitals closing, providers ...

Looking to usher in a more “predictable” year in 2026, Illumina is working with officials in China as it remains on the ...

Donald Trump’s destruction of the civil service is a tragedy not just for the roughly 300,000 workers who have been discarded ...

The Comptroller of Maryland, in collaboration with the University of Maryland's Robert H. Smith School of Business, has released a new scenario analysis, demonstrating the estimated, direct impact of ...

Tessera Therapeutics, a Somerville biotech with a valuation over $1 billion, is laying off 35% of its workforce.

Driven by rapid clinical translation, industrial-scale allogeneic production, and sustained public–private investment, the ...

We’re rounding up last week’s stories, from the fight over in-state tuition for undocumented Virginia students to the Trump ...

McCormick won what many viewed as an improbable victory, and he was determined to hit the ground running from the moment he ...

Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to hereditary neuronal sodium ion channel mutationsAdolore's Kv7 voltage-gated ...